|Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters|
KJ Cheung, V Padmanaban, V Silvestri, K Schipper, JD Cohen, ...
Proceedings of the National Academy of Sciences 113 (7), E854-E863, 2016
|BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants|
F Elstrodt, A Hollestelle, JHA Nagel, M Gorin, M Wasielewski, ...
Cancer research 66 (1), 41-45, 2006
|Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial|
R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ...
JAMA oncology 6 (5), 650-659, 2020
|Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry|
PM Pierorazio, MH Johnson, MW Ball, MA Gorin, BJ Trock, P Chang, ...
European urology 68 (3), 408-415, 2015
|Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations|
JJ Tosoian, MA Gorin, AE Ross, KJ Pienta, PT Tran, EM Schaeffer
Nature Reviews Urology 14 (1), 15-25, 2017
|Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging|
S Sheikhbahaei, A Afshar-Oromieh, M Eiber, LB Solnes, MS Javadi, ...
European journal of nuclear medicine and molecular imaging 44 (12), 2117-2136, 2017
|Protein kinase Cε: an oncogene and emerging tumor biomarker|
MA Gorin, Q Pan
Molecular cancer 8 (1), 1-8, 2009
|PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges|
SP Rowe, MA Gorin, ME Allaf, KJ Pienta, PT Tran, MG Pomper, AE Ross, ...
Prostate cancer and prostatic diseases 19 (3), 223-230, 2016
|Positive surgical margins in robot-assisted partial nephrectomy: a multi-institutional analysis of oncologic outcomes (leave no tumor behind)|
A Khalifeh, JH Kaouk, S Bhayani, C Rogers, M Stifelman, YS Tanagho, ...
The Journal of urology 190 (5), 1674-1679, 2013
|Grade heterogeneity in small renal masses: potential implications for renal mass biopsy|
MW Ball, SM Bezerra, MA Gorin, M Cowan, CP Pavlovich, PM Pierorazio, ...
The Journal of urology 193 (1), 36-40, 2015
|Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18 F-DCFPyL PET/CT|
SP Rowe, MA Gorin, HJ Hammers, MS Javadi, H Hawasli, Z Szabo, ...
Annals of nuclear medicine 29 (10), 877-882, 2015
|Prospective evaluation of 99mTc-sestamibi SPECT/CT for the diagnosis of renal oncocytomas and hybrid oncocytic/chromophobe tumors|
MA Gorin, SP Rowe, AS Baras, LB Solnes, MW Ball, PM Pierorazio, ...
European urology 69 (3), 413-416, 2016
|Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis|
MA Gorin, MW Ball, PM Pierorazio, YS Tanagho, SB Bhayani, JH Kaouk, ...
The Journal of urology 190 (5), 1907-1911, 2013
|Pomegranate fruit extract impairs invasion and motility in human breast cancer|
GN Khan, MA Gorin, D Rosenthal, Q Pan, LW Bao, ZF Wu, RA Newman, ...
Integrative cancer therapies 8 (3), 242-253, 2009
|Proposal for a structured reporting system for prostate-specific membrane antigen–targeted PET imaging: PSMA-RADS version 1.0|
SP Rowe, KJ Pienta, MG Pomper, MA Gorin
Journal of Nuclear Medicine 59 (3), 479-485, 2018
|Imaging of nonprostate cancers using PSMA-targeted radiotracers: rationale, current state of the field, and a call to arms|
RAS Fragomeni, T Amir, S Sheikhbahaei, SC Harvey, MS Javadi, ...
Journal of Nuclear Medicine 59 (6), 871-877, 2018
|Safety and early oncologic effectiveness of primary robotic retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer|
SM Pearce, S Golan, MA Gorin, AN Luckenbaugh, SB Williams, JF Ward, ...
European urology 71 (3), 476-482, 2017
|Technical challenges in the isolation and analysis of circulating tumor cells|
EE van der Toom, JE Verdone, MA Gorin, KJ Pienta
Oncotarget 7 (38), 62754, 2016
|Growth kinetics of small renal masses on active surveillance: variability and results from the DISSRM registry|
AC Uzosike, HD Patel, R Alam, ZR Schwen, M Gupta, MA Gorin, ...
The Journal of urology 199 (3), 641-648, 2018
|A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)|
N Radwan, R Phillips, A Ross, SP Rowe, MA Gorin, ES Antonarakis, ...
BMC cancer 17 (1), 1-9, 2017